Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending life, according to a new study. This trend is problematic because these men may not have life expectancies that would allow them to receive the benefits of more aggressive treatments.
http://dlvr.it/TG7GBw
